|
Volumn 15, Issue 1_suppl, 2009, Pages 05S-08S
|
Oral Antithrombotic Inhibitors: Dabigatran Etexilate, Meeting an Unmet Need?
|
Author keywords
anticoagulants; dabigatran; oral antithrombotic inhibitors
|
Indexed keywords
DABIGATRAN ETEXILATE;
ENOXAPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
THROMBIN;
ANTICOAGULANT AGENT;
BENZIMIDAZOLE DERIVATIVE;
FIBRINOLYTIC AGENT;
PYRIDINE DERIVATIVE;
ANTICOAGULATION;
ARTICLE;
ATRIAL FIBRILLATION;
BLEEDING;
CEREBROVASCULAR ACCIDENT;
DOSE RESPONSE;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG SAFETY;
HIGH RISK PATIENT;
HIP ARTHROPLASTY;
HUMAN;
KNEE ARTHROPLASTY;
MAXIMUM PLASMA CONCENTRATION;
MULTICENTER STUDY (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SINGLE DRUG DOSE;
TREATMENT OUTCOME;
VENOUS THROMBOEMBOLISM;
BLOOD;
BLOOD CLOTTING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG EFFECT;
EDITORIAL;
EVIDENCE BASED MEDICINE;
ORAL DRUG ADMINISTRATION;
RISK ASSESSMENT;
ADMINISTRATION, ORAL;
ANTICOAGULANTS;
ARTHROPLASTY, REPLACEMENT, HIP;
ARTHROPLASTY, REPLACEMENT, KNEE;
BENZIMIDAZOLES;
BLOOD COAGULATION;
CLINICAL TRIALS AS TOPIC;
EVIDENCE-BASED MEDICINE;
FIBRINOLYTIC AGENTS;
HEMORRHAGE;
HUMANS;
PYRIDINES;
RISK ASSESSMENT;
THROMBIN;
VENOUS THROMBOEMBOLISM;
|
EID: 77957090426
PISSN: 10760296
EISSN: 19382723
Source Type: Journal
DOI: 10.1177/1076029609344427 Document Type: Article |
Times cited : (5)
|
References (5)
|